Literature DB >> 19003265

Toxic concentrations of exogenously supplied methylglyoxal in hybridoma cell culture.

Benjamin M Roy1, Tiffany D Rau, R Robert Balcarcel.   

Abstract

Concentrations at which methylglyoxal, a by-product of cellular metabolism, can be toxic to hybridoma cell cultures were determined using exogenously supplied doses. Trypan blue cell counts of 6-well cultures incubated for 24 h with various methylglyoxal concentrations revealed inhibition of cell growth at 300 muM and higher, with a median inhibitory concentration of 490+/-20 muM. The primary mode of death was apoptosis, as assessed by chromatin condensation, and the effects of methylglyoxal were observed to be complete by approximately eight hours. Yet, the impact of methylglyoxal was a function of the rate of dosing; stepwise addition of MG during the first 6 h of incubation inhibited growth but caused much less cell death than a comparable bolus dose. Inhibition of cellular metabolism by MG was found to coincide with inhibition of cell growth, with a comparable median inhibitory concentration of 360+/-20 muM. The effects on viable cell density and metabolism were both linear at doses approaching zero, with lowest observable effect levels of 54 and 77 muM, respectively. These results provide quantitative estimates for concentrations of methylglyoxal that may be inhibitory to biopharmaceutical-producing cell lines.

Entities:  

Year:  2005        PMID: 19003265      PMCID: PMC3449709          DOI: 10.1007/s10616-005-0301-5

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  31 in total

1.  The lactate issue revisited: novel feeding protocols to examine inhibition of cell proliferation and glucose metabolism in hematopoietic cell cultures.

Authors:  S D Patel; E T Papoutsakis; J N Winter; W M Miller
Journal:  Biotechnol Prog       Date:  2000 Sep-Oct

2.  Alteration of mammalian cell metabolism by dynamic nutrient feeding.

Authors:  W Zhou; J Rehm; A Europa; W S Hu
Journal:  Cytotechnology       Date:  1997-07       Impact factor: 2.058

3.  Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells.

Authors:  F W Chaplen; W E Fahl; D C Cameron
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Modification of the glyoxalase system in human red blood cells by glucose in vitro.

Authors:  P J Thornalley
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

5.  Kinetic analysis of the human erythrocyte glyoxalase system using 1H NMR and a computer model.

Authors:  C Rae; S J Berners-Price; B T Bulliman; P W Kuchel
Journal:  Eur J Biochem       Date:  1990-10-05

Review 6.  Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor.

Authors:  P J Thornalley
Journal:  Crit Rev Oncol Hematol       Date:  1995-08       Impact factor: 6.312

7.  Effect of lactic acid on the kinetics of growth and antibody production in a murine hybridoma: secretion patterns during the cell cycle.

Authors:  S J Kromenaker; F Srienc
Journal:  J Biotechnol       Date:  1994-04-30       Impact factor: 3.307

8.  Effects of ammonia and lactate on growth, metabolism, and productivity of BHK cells.

Authors: 
Journal:  Enzyme Microb Technol       Date:  2000-07-01       Impact factor: 3.493

9.  Growth inhibition in animal cell culture. The effect of lactate and ammonia.

Authors:  T Hassell; S Gleave; M Butler
Journal:  Appl Biochem Biotechnol       Date:  1991-07       Impact factor: 2.926

10.  Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin.

Authors:  T W Lo; M E Westwood; A C McLellan; T Selwood; P J Thornalley
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.